Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment

BACKGROUND/AIMS: Several treatment options are currently available for patients with hepatocellular carcinoma (HCC) failing previous sorafenib treatment. We aimed to compare the effectiveness of regorafenib and nivolumab in these patients. METHODS: Consecutive HCC patients who received regorafenib o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Mol Hepatol
Asıl Yazarlar: Lee, Cheol-Hyung, Lee, Yun Bin, Kim, Minseok Albert, Jang, Heejoon, Oh, Hyunwoo, Kim, Sun Woong, Cho, Eun Ju, Lee, Kyung-Hun, Lee, Jeong-Hoon, Yu, Su Jong, Yoon, Jung-Hwan, Kim, Tae-You, Kim, Yoon Jun
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The Korean Association for the Study of the Liver 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7364358/
https://ncbi.nlm.nih.gov/pubmed/32460459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2019.0049n
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller